News Breaks |
|
|
| March 15, 2013 |
| 06:30 EDT |  | MDCO | The Medicines Co. initiated with an Outperform at Credit Suisse
Target $38. |
|
|
News For MDCO From The Last 14 Days Check below for free stories on MDCO the last two weeks. |
|
|
| June 6, 2013 |
| 10:01 EDT | | MDCO | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Cadence (CADX) initiated with a Neutral at Piper Jaffray... Costco (COST) initiated with a Buy at Sterne Agee... Dollar General (DG) initiated with a Neutral at Sterne Agee... Dollar Tree (DLTR) initiated with a Buy at Sterne Agee... Emeritus (ESC) initiated with a Neutral at Goldman... Enbridge (ENB) initiated with an Outperform at Macquarie... ExOne (XONE) initiated with a Buy at Canaccord... Family Dollar (FDO) initiated with a Neutral at Sterne Agee... Five Below (FIVE) initiated with a Neutral at Sterne Agee... Haemonetics (HAE) initiated with an Outperform at JMP Securities... ING Group (ING) initiated with a Buy at Jefferies... J.C. Penney (JCP) initiated with a Buy at Sterne Agee... Kohl's (KSS) initiated with a Neutral at Sterne Agee... Macy's (M) initiated with a Buy at Sterne Agee... Nordstrom (JWN) initiated with a Buy at Sterne Agee... Saks (SKS) initiated with a Neutral at Sterne Agee... Signature Bank (SBNY) initiated with an Overweight at Morgan Stanley... The Fresh Market (TFM) initiated with a Buy at Sterne Agee... The Medicines Co. (MDCO) initiated with an Overweight at Piper Jaffray... Vitamin Shoppe (VSI) initiated with a Buy at Sterne Agee... Whole Foods (WFM) initiated with a Buy at Sterne Agee... SkyWest (SKYW) initiated with an In-Line at Imperial Capital... W&T Offshore (WTI) initiated with a Buy at SunTrust... Canadian Natural (CNQ) initiated with an Accumulate at Global Hunter... Cenovus Energy (CVE) initiated with a Buy at Global Hunter... Suncor (SU) initiated with a Buy at Global Hunter... Freeport McMoRan (FCX) coverage resumed with a Buy at Jefferies. |
|
| 05:58 EDT | | MDCO | The Medicines Co. initiated with an Overweight at Piper Jaffray
Target $47. |
|
| June 4, 2013 |
| 06:08 EDT |  | MDCO | The Medicines Co. to acquire ProFibrix
The Medicines Company and ProFibrix B.V. announced an agreement for The Medicines Company to purchase all of the outstanding capital stock of ProFibrix B.V. subject to The Medicines Company's satisfactory review of the pending Phase 3 clinical trial results of ProFibrix's lead biologic, Fibrocaps. Under the terms of the agreement, The Medicines Company will pay ProFibrix a $10M upfront option payment. If the Medicines Company is satisfied with the trial results of FINISH-3 and determines to proceed, it will purchase all of the outstanding capital stock of ProFibrix at closing. Otherwise, The Medicines Company may terminate the transaction with no further obligation to the ProFibrix shareholders. ProFibrix shareholders could receive additional payments related to achieving U.S. and European regulatory approvals and sales milestones. |
|
|
|
|
|
